Corona vaccination / vaccination against COVID-19 in Munich

Vaccinations have been a central focus of Dr. Frühwein Partner’s practice for more than 70 years. With Dr. Markus Frühwein and Dr. Nikolaus Frühwein, two proven vaccination experts are at your side with knowledge and advice. With more than 770 million confirmed cases and almost 7 million deaths worldwide, the coronavirus pandemic caused by SARS-CoV-2 is certainly the most serious health challenge of this century. It is assumed that the number of cases and deaths is significantly higher due to underreporting. Germany was also severely affected, with over 38 million confirmed cases and over 170,000 deaths. The pandemic was contained thanks to the global use of COVID-19 vaccines. Nevertheless, COVID-19 will probably continue to accompany us as a risk disease in everyday life in the distant future. To date, vaccination is the best protection against the disease, especially severe cases. Here you will find information and answers to frequently asked questions about vaccination against COVID-19 at our practice in Munich.

The STIKO recommendations have changed frequently in recent years. In most cases, vaccination is no longer necessary, especially for healthy, younger adults. This also applies during pregnancy. Vaccination is also no longer recommended for healthy children and adolescents. Every person in the following groups should have at least basic immunity against COVID-19 (corresponding to 3 contacts, including at least 1 vaccination. No further vaccinations are then recommended.

In addition to basic immunity, a booster vaccination with the current, adapted vaccine in the fall is recommended for the following groups:

The STIKO no longer recommends basic immunization or booster vaccinations for children and adolescents who have no underlying diseases, as the majority of cases in this age group are now mild. If there is an individual risk, e.g. pre-existing conditions, basic immunization should be carried out with annual boosters.

The current adapted vaccine is directed against the JN.1 variant, an Omikron variant. According to current data, the vaccine works well against the circulating strains including the KP.3 variant.